Lupin receives USFDA approval for generic Clobex Lotion

25 Sep 2017 Evaluate

Lupin has received final approval for its Clobetasol Propionate Lotion, 0.05% from the United States Food and Drug Administration (USFDA) to market a generic version of Galderma Laboratories, L.P.’s Clobex Lotion, 0.05%. Clobex Lotion, 0.05% had US sales of $14.3 million, as per IMS MAT June 2017.

Lupin’s Clobetasol Propionate Lotion, 0.05% is the AB rated generic equivalent of Galderma Laboratories, L.P.’s Clobex Lotion, 0.05%. It is a corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses, in patients 18 years of age or older.

Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally.


Lupin Share Price

2052.05 -19.30 (-0.93%)
09-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1776.20
Dr. Reddys Lab 1246.25
Cipla 1490.70
Zydus Lifesciences 919.90
Lupin 2052.05
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×